[Effects of green tea on growth inhibition and immune regulation of Lewis lung cancer in mice] NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Effects of green tea on growth inhibition and immune regulation of Lewis lung cancer in mice]

Chung Hua Yu Fang I Hsueh Tsa Chih. 1997 Nov;31(6):325-9. Unique Identifier : AIDSLINE MED/99080198
Zhu M; Gong Y; Ge G; Institute of Radiation Medicine, Academy of Military Medical; Sciences, Beijing.

Abstract: C57/BL6J mice were inoculated with Lewis lung cancer cells as an experimental model to study the effects of green tea on cancer prevention, inhibition of tumor growth and immune regulation in mice with tumor. Results showed that weight of thymus in C57/BL6J mice and its index declined, proportion of positive CD4 subgroup of T lymphocyte and ratio of CD4+, to CD8+ reduced, baseline chemilumi-nescence decreased in peripheral white blood cells, yeast zymosan stimulated chemiluminescence increased, and number of immunoglobulin M formation cells decreased. It indicated that green tea had obvious inhibition in Lewis lung cancer and protective effects, to various extent, on adverse changes of above indices.
Keywords: JOURNAL ARTICLE Adjuvants, Immunologic/*PHARMACOLOGY Animal Antineoplastic Agents/*PHARMACOLOGY Carcinoma, Lewis Lung/IMMUNOLOGY/*PATHOLOGY Chemiluminescence CD4-CD8 Ratio English Abstract Female In Vitro Leukocytes/IMMUNOLOGY Mice Mice, Inbred C57BL Neoplasm Transplantation Plant Extracts/PHARMACOLOGY Support, Non-U.S. Gov't T-Lymphocytes/*IMMUNOLOGY *TeaKWDjournalarticleadjuvants,immunologic/KWDpharmacologyanimalantineoplasticagents/KWDpharmacologycarcinoma,lewislung/immunology/KWDpathologychemiluminescencecd4-cd8ratioenglishabstractfemaleinvitroleukocytes/immunologymicemice,inbredc57blneoplasmtransplantationplantextracts/pharmacologysupport,non-uKWDsKWDgov'tt-lymphocytes/KWDimmunologyKWDtea
990530
A9950885

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .